Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases

被引：17
|
作者：
Levin, JI
Gu, YS
Nelson, FC
Zask, A
DiJoseph, JF
Sharr, MA
Sung, A
Jin, GX
Cowling, R
Chanda, P
Cosmi, S
Hsiao, CL
Edris, W
Wilhelm, J
Killar, LM
Skotnicki, JS
机构：
[1] Wyeth Ayerst Res, Pearl River, NY 10965 USA
[2] Wyeth Ayerst Res, Princeton, NJ 08543 USA
[3] Wyeth Ayerst Res, Cambridge, MA 02140 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 02期
关键词：
D O I：
10.1016/S0960-894X(00)00644-2
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Heteroaryl and cycloalkyl sulfonamide-hydroxamic acid MMP inhibitors were investigated. Of these, the pyridyl analogue 2 is the most potent and selective inhibitor of MMP-9 and MMP-13 in vitro. (C) 2001 Elsevier Science Ltd. hll rights reserved.
引用
收藏
页码：239 / 242
页数：4
相关论文
共 50 条
  • [1] Heteroaryl hydroxamic acid derivatives as novel histone deacetylase inhibitors
    Shirai, Fumiyuki
    Mukoyoshi, Koichiro
    Urano, Yasuharu
    Eikyu, Yoshiteru
    Ishibashi, Naoki
    Sawada, Yuki
    Kamijo, Kazunori
    Kozuki, Yoshihiro
    Satoh, Shigeki
    Masunaga, Taro
    Ohkubo, Mitsuru
    Ohta, Mitsuaki
    Tsukamoto, Shinichi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [2] Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors
    Zask, A
    Gu, Y
    Albright, JD
    Du, X
    Hogan, M
    Levin, JI
    Chen, JM
    Killar, LM
    Sung, A
    DiJoseph, JF
    Sharr, MA
    Roth, CE
    Skala, S
    Jin, G
    Cowling, R
    Mohler, KM
    Barone, D
    Black, R
    March, C
    Skotnicki, JS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (08) : 1487 - 1490
  • [3] Quantitative structure-activity relationship studies on matrix metalloproteinase inhibitors: Bicyclic heteroaryl hydroxamic acid analogs
    Gupta, SP
    Kumaran, S
    LETTERS IN DRUG DESIGN & DISCOVERY, 2005, 2 (07) : 522 - 528
  • [4] Phosphinic acid inhibitors of matrix metalloproteinases
    Caldwell, CG
    Sahoo, SP
    Polo, SA
    Eversole, RR
    Lanza, TJ
    Mills, SG
    Niedzwiecki, LM
    IzquierdoMartin, M
    Chang, BC
    Harrison, RK
    Kuo, DW
    Lin, TY
    Stein, RL
    Durette, PL
    Hagmann, WK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (03) : 323 - 328
  • [5] 3D-QSAR of sulfonamide hydroxamic acid HDAC inhibitors
    Liu, B
    Lu, AJ
    Liao, CZ
    Liu, HB
    Zhou, JJ
    ACTA PHYSICO-CHIMICA SINICA, 2005, 21 (03) : 333 - 337
  • [6] Thiomorpholine sulfonamide hydroxamic acid-based TACE inhibitors.
    Laakso, LM
    Levin, JI
    Du, ML
    Jin, GX
    Cowling, R
    Skala, S
    Cummons, T
    Xu, J
    Barone, D
    Skotnicki, JS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U21 - U21
  • [7] Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases
    Pikul, S
    Dunham, KLM
    Almstead, NG
    De, B
    Natchus, MG
    Anastasio, MV
    McPhail, SJ
    Snider, CE
    Taiwo, YO
    Chen, LY
    Dunaway, CM
    Gu, F
    Mieling, GE
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (01) : 87 - 94
  • [8] Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNFα processing
    M. DiMartino
    C. Wolff
    W. High
    G. Stroup
    S. Hoffman
    J. Laydon
    J. C. Lee
    D. Bertolini
    W. A. Galloway
    M. J. Crimmin
    M. Davis
    S. Davies
    Inflammation Research, 1997, 46 : 211 - 215
  • [9] The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases
    Skarja, Gary A.
    Brown, Allison L.
    Ho, Rebecca K.
    May, Michael H.
    Sefton, Michael V.
    BIOMATERIALS, 2009, 30 (10) : 1890 - 1897
  • [10] Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases
    Krumme, D
    Tschesche, H
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (06) : 933 - 936
12345